These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21624783)

  • 21. Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger.
    Kim JS; Oldenburg CE; Cooley G; Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Keenan JD; Gaynor BD; Porco TC; Lietman TM; Martin DL
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007127. PubMed ID: 30689671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of Chlamydia trachomatis ocular infection in trachoma-endemic communities by rRNA amplification.
    Yang JL; Hong KC; Schachter J; Moncada J; Lekew T; House JI; Zhou Z; Neuwelt MD; Rutar T; Halfpenny C; Shah N; Whitcher JP; Lietman TM
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):90-4. PubMed ID: 18689701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Mass Azithromycin Coverage Targets of Children in Niger: A Cluster-Randomized Trachoma Trial.
    Oldenburg CE; Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Gaynor BD; Keenan JD; Lietman TM
    Am J Trop Med Hyg; 2018 Feb; 98(2):389-395. PubMed ID: 29260659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction and return of infectious trachoma in severely affected communities in Ethiopia.
    Lakew T; House J; Hong KC; Yi E; Alemayehu W; Melese M; Zhou Z; Ray K; Chin S; Romero E; Keenan J; Whitcher JP; Gaynor BD; Lietman TM
    PLoS Negl Trop Dis; 2009; 3(2):e376. PubMed ID: 19190781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma.
    Melese M; Alemayehu W; Lakew T; Yi E; House J; Chidambaram JD; Zhou Z; Cevallos V; Ray K; Hong KC; Porco TC; Phan I; Zaidi A; Gaynor BD; Whitcher JP; Lietman TM
    JAMA; 2008 Feb; 299(7):778-84. PubMed ID: 18285589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia.
    Astale T; Sata E; Zerihun M; Nute AW; Stewart AEP; Gessese D; Ayenew G; Melak B; Chanyalew M; Tadesse Z; Callahan EK; Nash SD
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006270. PubMed ID: 29451881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma.
    Amza A; Kadri B; Nassirou B; Arzika AM; Austin A; Nyatigo F; Lebas E; Arnold BF; Lietman TM; Oldenburg CE
    BMC Ophthalmol; 2021 Jan; 21(1):15. PubMed ID: 33407263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term Forecasting of the Prevalence of Trachoma: Expert Opinion, Statistical Regression, versus Transmission Models.
    Liu F; Porco TC; Amza A; Kadri B; Nassirou B; West SK; Bailey RL; Keenan JD; Solomon AW; Emerson PM; Gambhir M; Lietman TM
    PLoS Negl Trop Dis; 2015 Aug; 9(8):e0004000. PubMed ID: 26302380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa.
    Last AR; Burr SE; Harding-Esch E; Cassama E; Nabicassa M; Roberts CH; Mabey DCW; Holland MJ; Bailey RL
    Parasit Vectors; 2017 Dec; 10(1):624. PubMed ID: 29282126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trachoma and antibiotic use: the 'A' in SAFE.
    West S
    Expert Rev Anti Infect Ther; 2012 Jan; 10(1):75-83. PubMed ID: 22149616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating household and community transmission of ocular Chlamydia trachomatis.
    Blake IM; Burton MJ; Bailey RL; Solomon AW; West S; Muñoz B; Holland MJ; Mabey DC; Gambhir M; Basáñez MG; Grassly NC
    PLoS Negl Trop Dis; 2009; 3(3):e401. PubMed ID: 19333364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma.
    Keenan JD; Ayele B; Gebre T; Moncada J; Stoller NE; Zhou Z; Porco TC; McCulloch CE; Gaynor BD; Emerson PM; Schachter J; Lietman TM
    Clin Infect Dis; 2012 Jan; 54(2):253-6. PubMed ID: 22095569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The easiest children to reach are most likely to be infected with ocular Chlamydia trachomatis in trachoma endemic areas of Niger.
    Amza A; Kadri B; Nassirou B; Yu SN; Stoller NE; Bhosai SJ; Zhou Z; McCulloch CE; West SK; Bailey RL; Keenan JD; Lietman TM; Gaynor BD
    PLoS Negl Trop Dis; 2013; 7(1):e1983. PubMed ID: 23326612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Number of years of annual mass treatment with azithromycin needed to control trachoma in hyper-endemic communities in Tanzania.
    West SK; Munoz B; Mkocha H; Gaydos CA; Quinn TC
    J Infect Dis; 2011 Jul; 204(2):268-73. PubMed ID: 21673038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for active trachoma and Chlamydia trachomatis infection in rural Ethiopia after mass treatment with azithromycin.
    Edwards T; Harding-Esch EM; Hailu G; Andreason A; Mabey DC; Todd J; Cumberland P
    Trop Med Int Health; 2008 Apr; 13(4):556-65. PubMed ID: 18282237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of Trachoma from Achham District, Nepal: A Cross-Sectional Study from the Nepal National Trachoma Program.
    Pant BP; Bhatta RC; Chaudhary JS; Awasthi S; Mishra S; Sharma S; Cuddapah PA; Gwyn SE; Stoller NE; Martin DL; Keenan JD; Lietman TM; Gaynor BD
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004462. PubMed ID: 26871898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eliminating trachoma in areas with limited disease.
    Gaynor BD; Miao Y; Cevallos V; Jha H; Chaudary JS; Bhatta R; Osaki-Holm S; Yi E; Schachter J; Whitcher JP; Lietman T
    Emerg Infect Dis; 2003 May; 9(5):596-8. PubMed ID: 12737745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a Single Dose of Azithromycin for Trachoma in Low-Prevalence Communities.
    Wilson N; Goodhew B; Mkocha H; Joseph K; Bandea C; Black C; Igietseme J; Munoz B; West SK; Lammie P; Kasubi M; Martin DL
    Ophthalmic Epidemiol; 2019 Feb; 26(1):1-6. PubMed ID: 30543311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying a sufficient core group for trachoma transmission.
    Lietman TM; Deiner MS; Oldenburg CE; Nash SD; Keenan JD; Porco TC
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006478. PubMed ID: 30296259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complete elimination is a difficult goal for trachoma programs in severely affected communities.
    Gill DA; Lakew T; Alemayehu W; Melese M; Zhou Z; House JI; Hong KC; Ray KJ; Gandhi N; Whitcher JP; Gaynor BD; Lietman TM
    Clin Infect Dis; 2008 Feb; 46(4):564-6. PubMed ID: 18194094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.